The nuclear-fuel squeeze is easier to identify than to invest in. Much of the Western enrichment capacity that matters is privately held, while the listed alternatives either dilute the exposure, carry their own supply constraints or ask investors to pay heavily for scarcity already recognised. These four show where the theme does – and doesn’t – reach public markets.

Sep 10, 2026
•
3 min read
